ZEAL:CPH
Zealand Pharma A/S
DKKÂ 225.10
arrow_downward
-0.97%(-2.20) 1D
Okt 15, 2:00:54 PM GMT+2 · DKK
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ZEAL...
Buksan
DKKÂ 227.00
Mataas
DKKÂ 227.90
Mababa
DKKÂ 225.00
Mkt. cap
16.56B
Avg. na dami
402.85K
Dami
127.01K
Mataas nang 52-wk
DKKÂ 556.00
Mababa nang 52-wk
DKKÂ 225.00
Mga natitirang share
71.61M
Bilang ng mga empleyado
578
Buksan
DKKÂ 227.00
Mataas
DKKÂ 227.90
Mababa
DKKÂ 225.00
Mkt. cap
16.56B
Avg. na dami
402.85K
Dami
127.01K
Mataas nang 52-wk
DKKÂ 556.00
Mababa nang 52-wk
DKKÂ 225.00
Mga natitirang share
71.61M
Bilang ng mga empleyado
578
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Euronext Markets: Real-time Stock Market Data | live
·
1 araw ang nakalipas
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion
Stock Titan
·
1 araw ang nakalipas
Up to nearly $1.2B in milestones is tied to Generate's planned AI research on obesity drugs.
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Tungkol sa Zealand Pharma A/S